Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
11/1/2002
 
First Published:
9/1/2000
1.
Phase II Pilot Study of Phenylbutyrate, Dexamethasone, and Sargramostim (GM-CSF) in Patients With Refractory or Relapsed T(8;21) Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NHLBI
NHLBI-00-H-0156
NCI-171, NCT00006240, 171
Last Modified:
5/22/2008
 
First Published:
10/6/2006
2.
Phase II Study of Phenylbutyrate and Valganciclovir in Patients With Relapsed or Refractory, Epstein-Barr Virus-Positive Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCSD-050126
ROCHE-VAL-108, NCT00387530
Last Modified:
2/1/2001
3.
Phase I Study of Oral Phenylbutyrate for Refractory Adult Solid Tumors or Lymphoma (Summary Last Modified 02/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
J-9616
JHOC-9616, NCI-T95-0017H, NCT00002909, T95-0017
Last Modified:
11/1/2001
 
First Published:
1/1/1998
4.
Phase I Study of Phenylbutyrate in Patients with Refractory Anaplastic Astrocytoma or Glioblastoma (Summary Last Modified 11/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
NABTT-9605
JHOC-NABTT-9605, NCI-T96-0086
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute